Literature DB >> 15181175

LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1.

Fabien Darfeuille1, Jens Bo Hansen, Henrik Orum, Carmelo Di Primo, Jean-Jacques Toulmé.   

Abstract

One of the major limitations of the use of phosphodiester oligonucleotides in cells is their rapid degradation by nucleases. To date, several chemical modifications have been employed to overcome this issue but insufficient efficacy and/or specificity have limited their in vivo usefulness. In this work conformationally restricted nucleotides, locked nucleic acid (LNA), were investigated to design nuclease resistant aptamers targeted against the HIV-1 TAR RNA. LNA/DNA chimeras were synthesized from a shortened version of the hairpin RNA aptamer identified by in vitro selection against TAR. The results indicate that these modifications confer good protection towards nuclease digestion. Electrophoretic mobility shift assays, thermal denaturation monitored by UV-spectroscopy and surface plasmon resonance experiments identified LNA/DNA TAR ligands that bind to TAR with a dissociation constant in the low nanomolar range as the parent RNA aptamer. The crucial G, A residues that close the aptamer loop remain a key structural determinant for stable LNA/DNA chimera-TAR complexes. This work provides evidence that LNA modifications alternated with DNA can generate stable structured RNA mimics for interacting with folded RNA targets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181175      PMCID: PMC434442          DOI: 10.1093/nar/gkh636

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Is a closing "GA pair" a rule for stable loop-loop RNA complexes?

Authors:  F Ducongé; C Di Primo; J J Toulme
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

2.  A retroviral RNA kissing complex containing only two G.C base pairs.

Authors:  C H Kim; I Tinoco
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 3.  Structure, recognition and discrimination in RNA aptamer complexes with cofactors, amino acids, drugs and aminoglycoside antibiotics.

Authors:  D J Patel; A K Suri
Journal:  J Biotechnol       Date:  2000-03       Impact factor: 3.307

Review 4.  Multiple biological roles associated with the repeat (R) region of the HIV-1 RNA genome.

Authors:  B Berkhout
Journal:  Adv Pharmacol       Date:  2000

5.  Inhibition of HIV tat-TAR interactions by an antisense oligo-2'-O-methylribonucleoside methylphosphonate.

Authors:  Tomoko Hamma; Anthony Saleh; Ikramul Huq; Tariq M Rana; Paul S Miller
Journal:  Bioorg Med Chem Lett       Date:  2003-06-02       Impact factor: 2.823

6.  Effects of RNA secondary structure on cellular antisense activity.

Authors:  T A Vickers; J R Wyatt; S M Freier
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

Review 7.  Tackling Tat.

Authors:  J Karn
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

8.  Structural studies of LNA:RNA duplexes by NMR: conformations and implications for RNase H activity.

Authors:  K Bondensgaard; M Petersen; S K Singh; V K Rajwanshi; R Kumar; J Wengel; J P Jacobsen
Journal:  Chemistry       Date:  2000-08-04       Impact factor: 5.236

9.  The conformations of locked nucleic acids (LNA).

Authors:  M Petersen; C B Nielsen; K E Nielsen; G A Jensen; K Bondensgaard; S K Singh; V K Rajwanshi; A A Koshkin; B M Dahl; J Wengel; J P Jacobsen
Journal:  J Mol Recognit       Date:  2000 Jan-Feb       Impact factor: 2.137

Review 10.  Synthetic oligonucleotides as RNA mimetics: 2'-modified Rnas and N3'-->P5' phosphoramidates.

Authors:  M Egli; S M Gryaznov
Journal:  Cell Mol Life Sci       Date:  2000-09       Impact factor: 9.261

View more
  25 in total

1.  Ion trap collision-induced dissociation of locked nucleic acids.

Authors:  Teng-yi Huang; Anastasia Kharlamova; Scott A McLuckey
Journal:  J Am Soc Mass Spectrom       Date:  2009-09-30       Impact factor: 3.109

2.  DNA/RNA Fluorescence Imaging by Synthetic Nucleic Acids.

Authors:  Akimitsu Okamoto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.

Authors:  Kathrin S Schmidt; Sandra Borkowski; Jens Kurreck; Andrew W Stephens; Rolf Bald; Maren Hecht; Matthias Friebe; Ludger Dinkelborg; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2004-10-27       Impact factor: 16.971

Review 4.  Aptamers and the next generation of diagnostic reagents.

Authors:  Varatharasa Thiviyanathan; David G Gorenstein
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

Review 5.  In vitro selection of BNA (LNA) aptamers.

Authors:  Masayasu Kuwahara; Satoshi Obika
Journal:  Artif DNA PNA XNA       Date:  2013 Apr-Jun

6.  Inhibition of HIV Replication by Cyclic and Hairpin PNAs Targeting the HIV-1 TAR RNA Loop.

Authors:  Gregory Upert; Audrey Di Giorgio; Alok Upadhyay; Dinesh Manvar; Nootan Pandey; Virendra N Pandey; Nadia Patino
Journal:  J Nucleic Acids       Date:  2012-09-17

7.  Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein.

Authors:  Amy Davidson; Krystyna Patora-Komisarska; John A Robinson; Gabriele Varani
Journal:  Nucleic Acids Res       Date:  2010-08-19       Impact factor: 16.971

8.  Delivery systems for in vivo use of nucleic Acid drugs.

Authors:  R R Resende; H A M Torres; K K Yuahasi; Majumder P; Ulrich H
Journal:  Drug Target Insights       Date:  2007-08-09

9.  DNA mimics for the rapid identification of microorganisms by fluorescence in situ hybridization (FISH).

Authors:  Laura Cerqueira; Nuno F Azevedo; Carina Almeida; Tatiana Jardim; Charles William Keevil; Maria J Vieira
Journal:  Int J Mol Sci       Date:  2008-10-20       Impact factor: 5.923

Review 10.  Molecular beacons of xeno-nucleic acid for detecting nucleic acid.

Authors:  Qi Wang; Lei Chen; Yitao Long; He Tian; Junchen Wu
Journal:  Theranostics       Date:  2013-05-05       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.